This compound is a peptide synthesis intermediate, specifically a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group. It is a complex, flexible molecule with multiple stereocenters, commonly used in solid-phase peptide synthesis for constructing modified peptide chains.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 863971-44-2
Fmoc-AEEA-AEEA
pharmaceutical intermediate
N(alpha)-t-butoxycarbonyl-L-asparagine
pharmaceutical intermediate
L-Alanine benzyl ester 4-toluenesulfonate
pharmaceutical intermediate
Carbamic acid, ((4-(2-((bis(4-methylphenyl)methyl)amino)-2-oxoethoxy)phenyl)(2,4-dimethoxyphenyl)methyl)-, 9H-fluoren-9-ylmethyl ester
pharmaceutical intermediate
2,4-difluoro-α-(1H-1,2,4-triazolyl)acetophenone
pharmaceutical intermediate
(R)-(+)-3-(Dimethylamino)pyrrolidine dihydrochloride
pharmaceutical intermediate
5-Bromo-2-methyl-3-nitro-benzenamine
pharmaceutical intermediate
(alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine
pharmaceutical intermediate
(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoic acid
SMVBIYSFDNRJJI-FCUBIXSHSA-N
CC[C@H](C)[C@@H]([C@@H](CC(=O)O)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13